NNLX

 
Common Stock Dark or Defunct
Pink No Information
Contact Info
  • 843 North Main Street
  • Hubbard, OH 44425

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Sep 08, 2003
Audited Financials Not Available
CIK 0001030065
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: DE, USA
Year of Inc. 1989
Employees 11 a/o Jun 01, 2012
Company Officers/Contacts
Bret A. Barnhizer CEO, President
Daniel Barnhizer Esq.
Carol Surena Corporate Secretary
Joshua Barnhizer Corporate Counsel
Company Directors
Bret A. Barnhizer Chairman
Daniel Barnhizer
John Chatterton
Jeff Long
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel
Arnold & Porter LLP
399 Park Avenue
New York, NY, 10022
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Infectech, Inc. until 5-05
  • Note=6-00 company is in the development stage, researching & developing diagnostic tests for infectious human diseases
NNLX Security Details
Share Structure
Market Value1 $7,475,657 a/o Jun 23, 2017
Authorized Shares 200,000,000 a/o Dec 31, 2008
Outstanding Shares 119,610,510 a/o Jul 31, 2012
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 97,017,507 a/o Jul 31, 2012
Par Value 0.02
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders
Shareholders of Record 3,100 a/o Dec 31, 2011
Short Selling Data
Short Interest 40,535 (55.61%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security